Music Intervention for Dialysis Patients
Launched by NATIONAL UNIVERSITY OF SINGAPORE · Jun 22, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how listening to music can help people undergoing dialysis treatment for kidney failure. Researchers want to see if both live music and pre-recorded music can reduce feelings of pain, itchiness, anxiety, and depression, as well as improve the overall quality of life for patients. Participants will attend their regular dialysis sessions over four weeks. During the first week, they'll provide information about their experiences without music. In the second week, they'll listen to live music, and in the following weeks, they'll listen to pre-recorded music. The researchers will then compare the effects of both types of music against the initial data collected.
To participate in this trial, individuals must be between 21 and 90 years old, currently receiving dialysis treatment, and able to hear normally. They should also be willing to stay awake and listen to music during the sessions. However, people with dementia, cognitive impairments, or certain psychiatric disorders will not be eligible. This study aims to find out how music can positively impact the experience of dialysis, making it more enjoyable and less stressful for patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Are between 21 and 90 years old
- • Undergoing dialysis at the Corporation Road level 1 or Clementi NKF dialysis centre
- • Normal or corrected hearing
- • Willing to stay awake and listen during the music intervention
- • Are able to speak English, Mandarin, Malay, or Hokkien
- Exclusion Criteria:
- • Diagnosed dementia or cognitive impairment
- • Diagnosed psychiatric disorder
About National University Of Singapore
The National University of Singapore (NUS) is a leading global research university recognized for its commitment to advancing scientific knowledge and fostering innovation in healthcare. With a strong emphasis on interdisciplinary collaboration, NUS conducts cutting-edge clinical trials aimed at addressing critical health challenges and improving patient outcomes. The university's state-of-the-art facilities, coupled with its team of renowned researchers and clinicians, enable the development and evaluation of novel therapies and interventions. NUS is dedicated to translating research findings into practical applications, ultimately enhancing the quality of care and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Singapore, , Singapore
Singapore, , Singapore
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported